Jan 02, 2020
Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus
Nov 18, 2019
Triple-Gene Presented Preliminary Phase 1 Trial Data of Investigational Multigenic Therapeutic Candidate INXN-4001 for Treatment of Heart Failure at American Heart Association Annual Meeting
Nov 07, 2019
Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN-4001, First Multigenic Investigational Therapeutic Candidate for Treatment of Heart Failure
Nov 04, 2019
Intrexon to Announce Third Quarter Financial Results on November 12th
Jun 03, 2019
Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly(TM) Aedes aegypti Technology
May 28, 2019
Intrexon to Participate in 2019 BIO International Convention
May 13, 2019
Intrexon to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference
May 09, 2019
Intrexon Reports First Quarter 2019 Financial Results
May 02, 2019
Intrexon to Release First Quarter 2019 Financial Results on May 9th
Apr 29, 2019
Intrexon and Xogenex Present at American Society of Gene and Cell Therapy Annual Meeting
Jan 02, 2019
Intrexon Announces Presentations at Upcoming Investor Conferences
Dec 31, 2018
Precigen to Debut Portfolio at Investor Event during the 37th Annual J.P. Morgan Healthcare Conference
Dec 21, 2018
Exemplar Genetics and Mayo Clinic Launch Joint Venture Focused on Development of Human Liver Cells to Advance Medical Research
Dec 20, 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Dec 18, 2018
Intrexon and AquaBounty Receive Regulatory Exemption in Development of Gene Edited Tilapia for More Sustainable Production
Nov 01, 2018
Intrexon to Announce Third Quarter 2018 Financial Results on November 8th
Oct 18, 2018
Oxitec to Develop 2nd Friendly(TM) Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes
Sep 24, 2018
Intrexon Announces Advances in Production of Medical Cannabis
Sep 12, 2018
Intrexon Announces Transfer of Stock Listing to Nasdaq
Aug 09, 2018
Intrexon Business Update and Conference Call